BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7944625)

  • 1. Methotrexate-related pulmonary complications in patients with rheumatoid arthritis: cluster of five cases in a period of three months.
    Barrera P; Van Ede A; Laan RF; Van Riel PL; Boerbooms AM; Van De Putte LB
    Ann Rheum Dis; 1994 Jul; 53(7):479-80. PubMed ID: 7944625
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate-related pulmonary complications in rheumatoid arthritis.
    Barrera P; Laan RF; van Riel PL; Dekhuijzen PN; Boerbooms AM; van de Putte LB
    Ann Rheum Dis; 1994 Jul; 53(7):434-9. PubMed ID: 7944614
    [No Abstract]   [Full Text] [Related]  

  • 3. Does methotrexate cause interstitial lung disease in rheumatoid arthritis: What is the evidence?
    Malaviya AN
    Int J Rheum Dis; 2020 Jun; 23(6):713-716. PubMed ID: 32573124
    [No Abstract]   [Full Text] [Related]  

  • 4. [Case reports. Methotrexate therapy may cause pneumonitis].
    Sköldstam L; Brudin L; Janner B; Thorstenson S
    Lakartidningen; 1994 Jun; 91(26-27):2582-4. PubMed ID: 8046977
    [No Abstract]   [Full Text] [Related]  

  • 5. [Methotrexate pneumonitis].
    Zingg K; Grossenbacher M; Conen D; Truninger K
    Praxis (Bern 1994); 1999 Mar; 88(13):573-8. PubMed ID: 10235032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five cases of interstitial lung disease after leflunomide was combined with methotrexate therapy.
    Rutanen J; Kononoff A; Arstila L; Elfving P; Koskela H; Kaipiainen-Seppänen O
    Scand J Rheumatol; 2014; 43(3):254-6. PubMed ID: 24650220
    [No Abstract]   [Full Text] [Related]  

  • 7. [Methotrexate pneumonitis. Important to minimize serious adverse effects in treatment of rheumatoid arthritis].
    Sturfelt G
    Lakartidningen; 1994 Jun; 91(26-27):2571-2. PubMed ID: 8046973
    [No Abstract]   [Full Text] [Related]  

  • 8. [Two fatal cases of methotrexate-induced interstitial pneumonitis].
    Matsushima H; Takayanagi N; Kawata I; Sakamoto T; Motegi M; Ubukata M; Yanagisawa T; Sugita Y; Kanazawa M; Kawabata Y
    Nihon Kokyuki Gakkai Zasshi; 2002 Mar; 40(3):249-55. PubMed ID: 11974902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent acute megaloblastic anaemia and pneumonitis: a severe side-effect of low-dose methotrexate therapy during rheumatoid arthritis.
    Bolla G; Disdier P; Harle JR; Verrot D; Weiller PJ
    Clin Rheumatol; 1993 Dec; 12(4):535-7. PubMed ID: 8124920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-A*31:01 and methotrexate-induced interstitial lung disease in Japanese rheumatoid arthritis patients: a multidrug hypersensitivity marker?
    Furukawa H; Oka S; Shimada K; ; Tsuchiya N; Tohma S
    Ann Rheum Dis; 2013 Jan; 72(1):153-5. PubMed ID: 22887846
    [No Abstract]   [Full Text] [Related]  

  • 11. Pneumonitis complicating low-dose methotrexate therapy for rheumatoid arthritis. Discrepancies between lung biopsy and bronchoalveolar lavage findings.
    Leduc D; De Vuyst P; Lheureux P; Gevenois PA; Jacobovitz D; Yernault JC
    Chest; 1993 Nov; 104(5):1620-3. PubMed ID: 8222842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toxicity of low-dose methotrexate in rheumatoid arthritis--clinical characteristics in patients with MTX-induced pancytopenia and interstitial pneumonitis].
    Ohosone Y; Okano Y; Kameda H; Hama N; Matsumura M; Nojima T; Nakamura K; Kuwana M; Ogasawara T; Hirakata M; Yoshida T; Mimori T; Akizuki M; Ikeda Y
    Ryumachi; 1997 Feb; 37(1):16-23. PubMed ID: 9128419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional barriers to clinical supervision for allied health professionals working in regional and remote settings.
    Matthews R
    Aust Health Rev; 2014 Feb; 38(1):118. PubMed ID: 24479990
    [No Abstract]   [Full Text] [Related]  

  • 14. Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis.
    Schnabel A; Richter C; Bauerfeind S; Gross WL
    Thorax; 1997 Apr; 52(4):377-9. PubMed ID: 9196524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial pneumonitis associated with infliximab therapy.
    Villeneuve E; St-Pierre A; Haraoui B
    J Rheumatol; 2006 Jun; 33(6):1189-93. PubMed ID: 16622902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate for rheumatoid arthritis: what should the patient be told?
    Ostor AJ; O'Gradaigh DR; Jenner JR
    Rheumatology (Oxford); 2003 Dec; 42(12):1576-8. PubMed ID: 14645872
    [No Abstract]   [Full Text] [Related]  

  • 17. Methotrexate and lung disease in rheumatoid arthritis.
    Conway R; Carey JJ
    Panminerva Med; 2017 Mar; 59(1):33-46. PubMed ID: 27711025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methotrexate for therapy of rheumatoid arthritis].
    Suzuki Y; Wakabayashi T; Jackson K
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():498-502. PubMed ID: 15799406
    [No Abstract]   [Full Text] [Related]  

  • 19. Can we finally exonerate methotrexate as a factor in causing or exacerbating fibrotic interstitial lung disease in patients with rheumatoid arthritis?
    Mehta P; Redhead G; Nair A; Sparks JA; Porter JC
    Clin Rheumatol; 2022 Oct; 41(10):2925-2928. PubMed ID: 35729371
    [No Abstract]   [Full Text] [Related]  

  • 20. Rheumatoid arthritis associated with methotrexate-induced pneumonitis: improvement with i.v. cyclophosphamide therapy.
    Suwa A; Hirakata M; Satoh S; Mimori T; Utsumi K; Inada S
    Clin Exp Rheumatol; 1999; 17(3):355-8. PubMed ID: 10410272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.